AI's expanding partner base and growing demand for C3 Generative AI solutions don't offer a buying opportunity due to higher investments in the near term.

(Bloomberg) -- GSK Plc, Sanofi and CSL Ltd. secured $72 million ... For a Master of Brutalist Provocations, a Modest Museum Appraisal Mexico City Restricts Airbnb Rentals to Curb ‘Gentrification ...

One of Europe’s best-performing equity funds has matched the steep gains of US tech without betting on the likes of Nvidia ...

One day after the WNBA ended its most successful season with the New York Liberty winning their ... France seeks job guarantees from Sanofi over Doliprane painkiller production The French ...

Health officials had previously filled nearly 5 million vaccines doses and expect the new funding to ... bird flu patient in Mexico died of other medical conditions Sanofi will also make sure ...

Companies drilling for the crude that turned the U.S. into the world's top oil producer face an unexpected dilemma: their ...

EU Mid-Market Update: Boeing tables 35% pay increase; Moldova's EU referendum leans towards joining; Eyes ahead for Q3 ...

Sanofi (SNY) stock gains as company exceeds Q3 earnings estimates with strong vaccine and Dupixent sales, and raises its full ...

Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat ...

French drug major Sanofi (SNYNF, SNY) reported third quarter net income attributable to equity holders of the company of 2.82 billion ...